Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis

Background: Renal tubulointerstitial fibrosis, a hallmark of chronic kidney disease (CKD), involves epithelial–mesenchymal transition (EMT), oxidative stress, and ferroptosis. This study investigated the renoprotective effects of isovitexin (ISOV) and its underlying molecular mechanisms. Materials and Methods: Male mice subjected to unilateral ureteral obstruction (UUO) were orally administered ISOV, while NRK52E cells were exposed to indoxyl sulfate (IS) with or without ISOV. Renal injury and molecular alterations were assessed using histopathology, immunohistochemistry, Western blotting, RT-qPCR, and immunofluorescence. Reactive oxygen species (ROS), lipid peroxidation, and intracellular ferrous iron were evaluated using flow cytometry, malondialdehyde assays, and FerroOrange staining, respectively. RNA sequencing, public single-cell RNA sequencing datasets, and molecular docking were employed to identify molecular targets IL-7 expression, and predict ISOV–IL-7 interactions. Results: ISOV significantly attenuated renal fibrosis, tubular injury, and EMT-associated markers. ISOV significantly attenuated IS-induced ROS accumulation, lipid peroxidation and intracellular ferrous iron (Fe2+) accumulation. Single-cell RNA sequencing analysis revealed elevated IL-7 expression in proximal tubular cells from CKD kidneys. Molecular docking predicted a potential interaction between ISOV and IL-7. Furthermore, ISOV suppressed IL-7 expression and AKT/mTOR phosphorylation, whereas IL-7 knockdown alleviated ferroptotic injury in NRK52E cells, suggesting that IL-7 contributes to the regulation of AKT/mTOR signaling and ferroptotic cell injury. Conclusions: ISOV exerts protective effects against renal tubulointerstitial fibrosis, potentially through suppression of the IL-7/AKT/mTOR signaling axis and ferroptosis, supporting its therapeutic potential for CKD-associated renal fibrosis.

Authors

Institutions

Publication Details

Journal
Antioxidants
Published
2026-11-20
DOI
https://doi.org/10.3390/antiox15111517
Primary Topic
Ferroptosis and cancer prognosis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis

Po-Yu Huang, Yi‐Hsien Hsieh, Yong‐Syuan Chen, Yi-Hsuan Ting et al.
2 links
Antioxidants
Ferroptosis and cancer prognosis
article

Isovitexin Attenuates Renal Tubulointerstitial Fibrosis by Targeting IL-7/AKT/mTOR-Mediated Ferroptosis

Po-Yu Huang, Yi‐Hsien Hsieh, Yong‐Syuan Chen, Yi-Hsuan Ting, Jen-Pi Tsai, Tung‐Wei Hung, Po-Yu Tsai, Yu-Hsun Lee
article en

Abstract

Background: Renal tubulointerstitial fibrosis, a hallmark of chronic kidney disease (CKD), involves epithelial–mesenchymal transition (EMT), oxidative stress, and ferroptosis. This study investigated the renoprotective effects of isovitexin (ISOV) and its underlying molecular mechanisms. Materials and Methods: Male mice subjected to unilateral ureteral obstruction (UUO) were orally administered ISOV, while NRK52E cells were exposed to indoxyl sulfate (IS) with or without ISOV. Renal injury and molecular alterations were assessed using histopathology, immunohistochemistry, Western blotting, RT-qPCR, and immunofluorescence. Reactive oxygen species (ROS), lipid peroxidation, and intracellular ferrous iron were evaluated using flow cytometry, malondialdehyde assays, and FerroOrange staining, respectively. RNA sequencing, public single-cell RNA sequencing datasets, and molecular docking were employed to identify molecular targets IL-7 expression, and predict ISOV–IL-7 interactions. Results: ISOV significantly attenuated renal fibrosis, tubular injury, and EMT-associated markers. ISOV significantly attenuated IS-induced ROS accumulation, lipid peroxidation and intracellular ferrous iron (Fe2+) accumulation. Single-cell RNA sequencing analysis revealed elevated IL-7 expression in proximal tubular cells from CKD kidneys. Molecular docking predicted a potential interaction between ISOV and IL-7. Furthermore, ISOV suppressed IL-7 expression and AKT/mTOR phosphorylation, whereas IL-7 knockdown alleviated ferroptotic injury in NRK52E cells, suggesting that IL-7 contributes to the regulation of AKT/mTOR signaling and ferroptotic cell injury. Conclusions: ISOV exerts protective effects against renal tubulointerstitial fibrosis, potentially through suppression of the IL-7/AKT/mTOR signaling axis and ferroptosis, supporting its therapeutic potential for CKD-associated renal fibrosis.

AntioxidantsVol. 15(11)
Tzu Chi University (TW), Tzu Chi Foundation (TW), Chung Shan Medical University Hospital (TW), Dalin Tzu Chi Hospital (TW), Chung Shan Medical University (TW)
Buddhist Tzu Chi Medical Foundation, Chung Shan Medical University Hospital
Good health and well-being
Ferroptosis and cancer prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon